- Country/Area (COUNTRY/AREA)
- Supranational group of countries (COUNTRY_GRP)
- Sex (SEX)
- Year of measure (YEAR)
- Andorra
- Monaco
-
Reduction of life expectancy through death before 65 years (Line chart)
-
Reduction of life expectancy through death before 65 years (Bar chart)
-
Reduction of life expectancy through death before 65 years (Map)
-
x px
-
European Health for All database (HFA-DB)
-
Health information system and data governance
-
Artificial Intelligence for Health in the WHO European Region
-
Assistive Technology
-
European Programme of Work
-
Digital Health
-
European mortality database (MDB)
-
Rehabilitation
-
Health-enhancing physical activity
-
European database on human and technical resources for health (HlthRes-DB)
-
Environment and Health Information System (ENHIS)
-
Financial protection in the European Region
-
Child and adolescent health
-
Seasonal influenza vaccination policies and coverage
-
Health Behaviour in School-aged Children (HBSC)
-
Maternal nutrition, physical activity and weight gain during pregnancy
-
Antimicrobial resistance
-
Global nutrition policy survey
-
Status of child and adolescent health policies in Europe
-
Health 2020 indicators
-
Global eHealth survey 2015
-
Joint Monitoring Framework (JMF)
Indicator code: E060301.T
Hypothetical increase in life expectancy if to set all mortality in age group 0-64 to zero. Calculated: le at 65+ 65 - le at birth.
Understanding the Reduction of Life Expectancy Through Death Before 65 Years
The indicator "Reduction of Life Expectancy Through Death Before 65 Years" serves as a critical measure in public health, shedding light on premature mortality rates within a population. This metric not only reflects the general health status of a community but also highlights the impact of various socio-economic factors and healthcare systems on life expectancy. By focusing on deaths that occur before the age of 65, this indicator helps identify key areas where health interventions can be most effective, aiming to extend the productive years of individuals and enhance overall societal well-being.
The Importance of Monitoring Premature Mortality
Tracking the reduction of life expectancy through death before 65 years is vital for governments and health organizations to understand and improve the health of their populations. This indicator not only informs on the effectiveness of health interventions but also helps in planning and prioritizing healthcare services. It is particularly important in detecting and addressing non-communicable diseases, lifestyle factors, and other preventable causes leading to premature deaths. Moreover, it assists in evaluating the impact of health policies over time, guiding future strategies to enhance population health and longevity.
Strengths and Limitations of the Premature Mortality Indicator
While the premature mortality indicator is a valuable tool for health assessment and planning, it comes with its own set of strengths and limitations.
Strengths
This indicator provides a quantifiable measure that can be standardized across different regions and time periods, allowing for effective comparisons and trend analyses. It is instrumental in highlighting the urgent health issues that need addressing, thereby facilitating targeted interventions. Furthermore, it helps mobilize resources towards the most impactful health challenges, potentially leading to significant improvements in public health and economic productivity.
Limitations
However, the accuracy of this indicator heavily depends on the quality of vital registration and data collection systems. In regions where data is incomplete or inaccurate, the estimates of premature mortality might not reflect the true scenario, leading to misinformed decisions. Additionally, this indicator does not account for the quality of life or morbidity; it strictly measures mortality, which might overlook important aspects of health and well-being that are affected by chronic but non-fatal diseases. Lastly, cultural, environmental, and genetic factors can also influence the data, which might complicate the interpretation of results across different populations.
Understanding both the strengths and limitations is crucial for effectively using the reduction of life expectancy through death before 65 years as a public health tool. It is essential for policymakers to consider these factors when designing health strategies and interventions aimed at reducing premature mortality and improving life expectancy.
-
% of population aged 0–14 years, males
-
% of population aged 0–14 years, females
-
% of population aged 65+ years
-
% of population aged 65+ years, males
-
% of population aged 65+ years, females
-
Live births per 1000 population, males
-
Live births per 1000 population, females
-
Number of live births
-
Number of live births, males
-
Number of live births, females